Searched for
PHARMA COS
Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...- India-Oman CEPA kicks in June 1: What gets cheaper, which sectors gain, and key benefits explainedIndia's Comprehensive Economic Partnership Agreement with Oman comes into effect on June 1, granting New Delhi 100% duty-free access for 98...
- USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facilityAjanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Focusing more on pharma cos with US exposure: Pawan Parakh“We are very clearly placed on companies which have got international exposure as far as pharmaceutical is concerned. Real estate continues...
- Cipla to tap foreign cos for large-scale vax playMoving beyond a wide portfolio of Covid drugs and diagnostic kits, the Mumbai-based company — with revenues of nearly Rs 20,000 crore — now...
- Indian govt's schizophrenia led to COVID ravages: Amartya SenIndia was better placed to fight the pandemic because of its pharma manufacturing prowess and also higher immunity levels, the noted econom...
- AstraZeneca further cuts EU vaccine supply target to 30 million: DocumentThe AstraZeneca document, shared with EU officials and dated March 10, shows that the company now expects to deliver 30.1 million doses by ...
- Seven Nifty firms that are likely to log over 50% jump in Q3 profitMotilal Oswal Securities expects the combined sales of Nifty constituents for the September-December period to fall 2 per cent YoY.
- Glenmark, Aurobindo should be part of core portfolio: Ajay BodkePharma stocks are trading at extremely high valuations and, thus, could especially be vulnerable to any disappointment, says Bodke.
- Competition, delay in drug approvals may take a toll on pharma cos' healthWith global macro-economic scenario turning volatile, Indian players may have to strategise harder to stay ahead.
- With attractive valuations, IT & pharma midcap stocks are worth a lookInvestors in technology and pharma sectors should partially book profits in largecap holdings and start investing their money in mid-cap st...
- Pharma companies adopt tough ethical normsAfter facing flak for illegal drug trials, and unethical marketing practices, the pharma industry seems to be pulling up its socks.
- Elder Pharmaceuticals gets suitability certificate from EDQM for DiosminDrug firm Elder Pharmaceuticals today said it has received certificate of suitability for 'Diosmin API', a drug used for the treatment of d...
- Buy Dr Reddy’s on declines: Mitesh ThackerProbably look to buy into if there are more corrections and if the stock price declines to 1400-1020 odd levels.
- 'Emerging biz in India on track for building leadership talent'Though there is a shortfall of ‘leaders’ in India , new biz and pharma cos are gradually bridging the demand-supply gap, according to consu...
- Emami frontrunner to bag Paras Pharma for about Rs 3,000 crEmami, which has shown a keen interest in Paras Pharma ever since the beginning of the bidding game, is understood to be shelling out aroun...
- Aurobindo allots 1.6 lakh equity shares to FCCB holdersDrug maker Aurobindo Pharma today said it has allotted 1.66 lakh shares worth 20 million dollars (about Rs 94 crore) to some of the company...
- Pharma cos focus on specialist therapiesPharma cos's emphasis is shifting to more focused therapies for specific cancers, immunological conditions and complex diseases.
- Blogs provide window to pharmaceutical industry in IndiaDiscussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...
Load More
